Apple, LinkedIn, and Twitter
Motley Fool Money1 Touko 2015

Apple, LinkedIn, and Twitter

Apple reports big earnings. LinkedIn and Twitter stumble. And Lumber Liquidators falls to a 3-year low. Our analysts discuss those stories and share some stocks on their radar. Plus, Motley Fool columnist Morgan Housel talks earnings, easy money, and misguided financial advice. Learn more about your ad choices. Visit megaphone.fm/adchoices

Jaksot(2111)

Tariffs Tangle Markets, Businesses, Investors

Tariffs Tangle Markets, Businesses, Investors

When uncertainty spikes, our ability to look out into the future shrinks. (00:21) Emily Flippen and Matt Argersinger discuss: - How the shifting tariff picture is driving uncertainty across markets...

7 Maalis 202540min

Kroger CEO Kicked Out of Grocery Store

Kroger CEO Kicked Out of Grocery Store

On the first call since Kroger CEO Rodney McMullen’s departure, not a mention of the former CEO was heard. (00:21) Nick Sciple and Ricky Mulvey discuss: - Kroger’s business results. - Why some invest...

6 Maalis 202531min

Crypto's New Backer

Crypto's New Backer

BlackRock wants to buy ports; Trump wants to buy crypto. (00:21) Asit Sharma and Mary Long discuss: - How investors can prepare for potential “disturbance.” - BlackRock’s latest acquisition. - The re...

5 Maalis 202534min

Tariffs Become Reality

Tariffs Become Reality

The Trump administration’s 25% tariffs on goods from Canada and Mexico are now in effect. Is this a negotiation tactic? A new long-term reality? (00:21) Jason Moser and Ricky Mulvey discuss: - The im...

4 Maalis 202531min

Now Serving: IPOs, Exits, Extra Cheese

Now Serving: IPOs, Exits, Extra Cheese

A fresh IPO, outgoing CEO, and Domino’s finally joining the field on stuffed-crust pizza. (00:21) Bill Barker and Dylan Lewis discuss: - Mixue’s splashy debut on the Hong Kong stock exchange, and ...

3 Maalis 202529min

The State of Weight-Loss Drugs

The State of Weight-Loss Drugs

$150 billion. That’s how much some experts estimate weight-loss drugs could bring in in sales within the next five years. Motley Fool analyst Karl Thiel joins Ricky Mulvey to check in on the GLP-1 l...

1 Maalis 202530min

Nvidia, Apple, and Eli Lilly: Manufacturing the Future

Nvidia, Apple, and Eli Lilly: Manufacturing the Future

The great buildout for AI and GLP-1 drugs continues. (00:21) Jason Moser and Matt Argersinger discuss: - How Nvidia continues to deliver in the face of great expectations, but even those great resu...

28 Helmi 202540min

What Drives Nvidia’s Growth?

What Drives Nvidia’s Growth?

The tech giant is a data center business. (00:21) Asit Sharma and Ricky Mulvey discuss: - Why Wall Street is shrugging off Nvidia’s 78% yearly revenue growth. - CEO Jensen Huang’s vision for AI in th...

27 Helmi 202524min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
rss-draivi
rss-lahtijat
oppimisen-psykologia
rss-rahamania
rss-porssipuhetta
taloudellinen-mielenrauha
rss-seuraava-potilas
rahapuhetta
rss-h-asselmoilanen
rss-paatos-podcast-suomen-kovimmat-paatoksentekijat-2
rss-paasipodi
rss-inderes
io-techin-tekniikkapodcast
pomojen-suusta
rss-viisas-raha-podi
rss-40-ajatusta-aanesta